Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_assertion description "[In addition, the combination of AICAr with antifolates [methotrexate (MTX) or pemetrexed] has been shown to further potentiate AMPK activation and to lead to greater cytotoxicity and growth inhibition in leukemia and other malignant cell types.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_assertion evidence source_evidence_literature NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_assertion SIO_000772 21262957 NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_assertion wasDerivedFrom befree-20150227 NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_assertion wasGeneratedBy ECO_0000203 NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP641878.RABv-BedJD9RFLhLtcC1Tju9cwPDA4lIBp0PiE7LdInQU130_provenance.